Zobrazeno 1 - 10
of 12
pro vyhledávání: '"33"'
Autor:
Ravi Kushwaha, M.R. Behera, Vikas Agarwal, Jithu Kurian, Monika Yacha, Amit Gupta, Vinita Agrawal, Manoj Jain, Narayan Prasad, Dharmendra Bhadauria
Publikováno v:
Lupus. 29:845-853
IntroductionLupus nephritis (LN) has a considerable impact on the morbidity and mortality of systemic lupus erythematosus (SLE) patients. Long-term comparative outcome data from the Indian subcontinent on treatment regimens with cyclophosphamide (CYP
Publikováno v:
Lupus. 22:1135-1141
Objective The objective of this paper is to evaluate the efficacy of combined mycophenolate mofetil (MMF) and tacrolimus (TAC) for lupus nephritis with suboptimal response to standard therapy. Methods Inclusion criteria for patients: (1) biopsy-confi
Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children
Autor:
Youssef M. Mosaad, Hazem Youssef, Ayman Hammad, Samir Elhanbly, A El Refaaey, Ashraf Bakr, F Elhusseini
Publikováno v:
Lupus. 22:486-491
Introduction More than 60% of children with systemic lupus erythematosus (SLE) develop lupus nephritis (LN). Neutrophil gelatinase-associated lipocalin (NGAL) is a protein secreted by leukocytes during inflammation and is overexpressed in the kidneys
Publikováno v:
Lupus. 19:1591-1598
We retrospectively analyzed the clinicopathologic characteristics and prognosis of 33 patients with diffuse proliferative lupus nephritis (class IV LN) complicated with thrombotic microangiopathy (TMA). Eighty-one percent of patients had renal dysfun
Publikováno v:
Lupus. 12:112-116
Thrombotic complications are a significant cause of morbidity and mortality in cancer patients. Studies in Caucasian populations have shown that up to one-third of such patients test positive to antiphospholipid antibodies. Our aim was to determine t
Publikováno v:
Lupus. 7:347-354
We measured the serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin) and soluble intercellular adhesion molecule-1 (sICAM-1) in 72 patients with systemic lupus erythematosus (SLE) (including patients w
Autor:
Omer Karadag, Yahya Buyukasik, Ali Akdogan, Levent Kilic, Sedat Kiraz, İsmail Doğan, Umit Akman, Şule Apraş Bilgen, Ihsan Ertenli
Publikováno v:
Lupus. 22(8)
Systemic lupus erythematosus (SLE) patients are at increased risk of thrombosis and cardiovascular diseases. Aspirin is an effective treatment option for these patients. The aim of this study was to investigate the presence of aspirin resistance in S
Autor:
Han Ls, Lin Zhang, Zhangsuo Liu, Hui Li, Yu-Jie He, Guanmin Gao, Xinyou Zhang, Xuejun Zeng, Zhaohui Zheng, Shengyun Liu, Jinyan Guo
Publikováno v:
Lupus. 22(5)
Our objective was to determine metabolic syndrome (MS) prevalence in Chinese patients with systemic lupus erythematosus (SLE) and to investigate the conditions that contribute to its development. 116 patients with SLE classified according to the Amer
Publikováno v:
Lupus. 18(4)
We report the clinicopathological features, treatment and outcome of 54 Indian children (14 boys) with biopsy-proven lupus nephritis followed over a 10-year period. The mean age (SD) at onset of disease was 9.6 ± 2.6 (range 2.5–14.4) years. Twenty
Autor:
Guillermo Ruiz-Irastorza, Jose Gabriel Erdozain, Irama Villar, Ciriaco Aguirre, Maider Garmendia, Agustin Martinez-Berriotxoa, Maria-Victoria Egurbide
Publikováno v:
Lupus. 16(10)
Fluctuations in the titers of anticardiolipin antibodies (aCL) have been reported in systemic lupus erythematosus (SLE) patients, but their relation with thrombosis is not completely understood. Prospective inception cohort of 237 patients with SLE (